The Toronto postliver transplantation hepatocellular carcinoma recurrence calculator: a machine learning approach

T Ivanics, W Nelson, MS Patel… - Liver …, 2022 - Wiley Online Library
Liver transplantation (LT) listing criteria for hepatocellular carcinoma (HCC) remain
controversial. To optimize the utility of limited donor organs, this study aims to leverage machine …

Dynamic risk profiling of HCC recurrence after curative intent liver resection

T Ivanics, CF Murillo Perez, MPAW Claasen… - …, 2022 - Wiley Online Library
Background and Aims Following liver resection (LR) for HCC, the likelihood of survival is
dynamic, in that multiple recurrences and/or metastases are possible, each having variable …

Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time?

G Sapisochin, T Ivanics, J Heimbach - Hepatology, 2022 - journals.lww.com
Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy
after HCC and has risen in incidence globally in the past decades. Intrahepatic …

Dynamic α-fetoprotein response and outcomes after liver transplant for hepatocellular carcinoma

…, P Tabrizian, VG Agopian, M Najjar, T Ivanics… - JAMA …, 2021 - jamanetwork.com
Importance Accurate preoperative prediction of hepatocellular carcinoma (HCC) recurrence
after liver transplant is the mainstay of selection tools used by transplant-governing bodies …

Adjuvant systemic therapy after resection of node positive gallbladder cancer: time for a well-designed trial?(Results of a US-national retrospective cohort study)

…, MC Hernandez, T Ivanics… - … Journal of Surgery, 2018 - journals.lww.com
Background Ideal oncologic management of gallbladder carcinoma (GBCA) after complete
surgical resection is unclear. We sought to define benefit of post-resection adjuvant systemic …

Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer

S Sanjeevi, T Ivanics, L Lundell, N Kartalis… - Journal of British …, 2016 - academic.oup.com
Background Locoregional pancreatic ductal adenocarcinoma (PDAC) may progress rapidly
and/or disseminate despite having an early stage at diagnostic imaging. A prolonged …

Implications of CA19‐9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: a national cohort analysis

JR Bergquist, T Ivanics, CB Storlie… - Journal of surgical …, 2016 - Wiley Online Library
Background Optimal management of patients with intrahepatic cholangiocarcinoma (ICCA)
and elevated CA19‐9 remains undefined. We hypothesized CA19‐9 elevation above normal …

Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection

WJ Choi, PJ Williams, MPAW Claasen, T Ivanics… - Annals of surgical …, 2022 - Springer
Background Recurrence rates of intrahepatic cholangiocarcinoma (iCCA) after curative
hepatectomy are as high as 50% to 70%, and about half of these recurrences occur within 2 …

Changing trends in liver transplantation: challenges and solutions

T Ivanics, P Abreu, E De Martin, G Sapisochin - Transplantation, 2021 - journals.lww.com
Despite improvements in postliver transplant outcomes through refinements in perioperative
management and surgical techniques, several changing trends in liver transplantation have …

[HTML][HTML] Novel benchmark values for redo liver transplantation: does the outcome justify the effort?

…, S Laroche, B Picard, S Shankar, T Ivanics… - Annals of …, 2022 - journals.lww.com
Objective: To define benchmark cutoffs for redo liver transplantation (redo-LT). Background:
In the era of organ shortage, redo-LT is frequently discussed in terms of expected poor …